Viewing Study NCT07164560


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-22 @ 6:37 AM
Study NCT ID: NCT07164560
Status: RECRUITING
Last Update Posted: 2025-09-10
First Post: 2025-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploratory Study of TRBC1/2-Targeted CAR-T Cell Therapy in Relapsed/Refractory Peripheral T-Cell Lymphoma
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory/Recurrent Peripheral T-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory/recurrent View
None TRBC1/2 CAR-T View
None Peripheral T-cell lymphoma View